%0 Journal Article
%T A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers
%A Arthur Catapang
%A Daniel Braas
%A Hanna M. Doh
%A Harvey R. Herschman
%A Jason T. Lee
%A Linsey Stiles
%A Orian Shirihai
%A Robert Damoiseaux
%A Shili Xu
%A Thomas G. Graeber
%J Archive of "Cancer & Metabolism".
%D 2018
%R 10.1186/s40170-018-0181-8
%X The online version of this article (10.1186/s40170-018-0181-8) contains supplementary material, which is available to authorized users
%K Precision medicine
%K Warburg effect
%K Liver cancer
%K Cancer
%K Glycolysis
%K Hexokinase 2
%K Diphenyleneiodonium
%K Perhexiline
%K Fatty acid oxidation
%K Oxidative phosphorylation
%K Mitochondria complex-I
%K Synthetic lethality
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022704/